Invention Grant
- Patent Title: 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
-
Application No.: US13294711Application Date: 2011-11-11
-
Publication No.: US08796319B2Publication Date: 2014-08-05
- Inventor: Andrew P. Combs , Eddy W. Yue , Richard B. Sparks , Wenyu Zhu , Jiacheng Zhou , Qiyan Lin , Lingkai Weng , Tai-Yuen Yue , Pingli Liu
- Applicant: Andrew P. Combs , Eddy W. Yue , Richard B. Sparks , Wenyu Zhu , Jiacheng Zhou , Qiyan Lin , Lingkai Weng , Tai-Yuen Yue , Pingli Liu
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D413/12 ; C07D271/08
Abstract:
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.
Public/Granted literature
- US20120058079A1 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase Public/Granted day:2012-03-08
Information query
